By Julien Pretot PARIS (Reuters) -When Luis Enrique claimed in early 2024 that Paris St Germain would be better without ...

The ItovebiTM (inavolisib)-based regimen reduced the risk of death by more than 30% in people with PIK3CA-mutated HR-positive ...

Key results from the interim analysis of the Phase 3 ENLIGHTED study of Padeliporfin VTP: As of November 5, 2024, the data ...